Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Frontlab DFT

What are the treatments for fronto temporal dementia (FTD)?

Last update: 21/12/2024 Reading time: 1min

There is currently no cure for fronto temporal dementia, but promising leads are emerging from ongoing research.

Treatments

Treatments for fronto temporal dementia (FTD)

The proposed treatments for FTD are only symptomatic in particular to alleviate the behavioural problems of patients. Some antidepressants or anxiolytics or serotonin (serotonin level regulators), for example, can reduce agitation with a noticeable effect on appetite regulation or irritability.

In all cases, treatment with medication must be complemented by speech therapy and/or day hospital treatment to restore social relations and undergo appropriate rehabilitation.

The care of patients must be multidisciplinary by a specialist team in an expert centre. It involves a neurologist as well as neuropsychologists, speech therapists and clinical psychologists. The patient's disorders and needs, family and social impact are thus assessed and appropriate care can be provided.

The impact of fronto-temporal degeneration on social, professional and family life is significant. The social and psychological aspect, the training of family caregivers in the disease, is also a major component of care. The support of patients and family carers by patients’ associations dedicated to this pathology, in particular the association France-DFT, is also crucial.

The reference center for rare or early dementias, “Fronto-temporal degeneration” at the Pitié-Salpêtrière hospital is a support structure for patient care.

https://cref-demrare.fr/Les-Degenerescences-Fronto-Temporales-DFT

Our news on the subject

lobes cerveau
Towards better management of disinhibition in frontotemporal dementia
Disinhibition is one of the main symptoms of the behavioural variant frontotemporal dementia (bvFTD), a type of dementia associated with degeneration of the frontal and temporal lobes of the brain. Patients with bvFTD exhibit behaviours that are...
01.30.2023 Research, science & health
cerveau
A better characterization of disinhibition in frontotemporal degeneration
Thanks to an approach combining behavioral assessment and brain imaging, a study conducted by the Paris Brain Institute's FrontLAB has led to a better characterization of a major symptom of frontotemporal degeneration, disinhibition. These results...
06.20.2022 Research, science & health
aphasie primaire progressive
Frontotemporal Degenerations and the Logopenic Variant of Primary Progressive Aphasia
A study published in the journal Neurology, conducted by Dario Saracino, Isabelle Le Ber (AP-HP), and their collaborators, highlights the importance of testing for mutations in a specific gene, the progranulin gene (GRN), in order to distinguish...
07.20.2021 Research, science & health
DFT sur un cerveau
Definition of new forms of the behavioural variant of frontotemporal degenerations (FTD)
Frontotemporal degeneration (FTD) is a complex neurodegenerative disorder that can manifest itself through a wide range of symptoms. Valérie Godefroy, postdoctoral researcher in the Frontlab, under the supervision of Lara Migliaccio, and her...
05.05.2021 Research, science & health
schéma
Discovery of a plasma signature of fronto-temporal degeneration and amyotrophic lateral sclerosis linked to a mutation of the C9orf72 gene
A joint study by teams from the Paris Brain Institute at the Pitié-Salpêtrière hospital and from Inria (Rennes and Paris centers) has revealed for the first-time plasma microRNA signatures in individuals with or presymptomatic of fronto-temporal...
12.04.2020 Research, science & health
image
Moral emotions, a diagnotic tool for frontotemporal dementia ?
A study conducted by Marc Teichmann and Carole Azuar at the Brain and Spine Institute in Paris (France) and at the Pitié-Salpêtrière Hospital shows a particularly marked impairment of moral emotions in patients with frontotemporal dementia (FTD). The...
06.07.2019 Research, science & health
See all our news